Literature DB >> 31643139

SETD2 related overgrowth syndrome: Presentation of four new patients and review of the literature.

Pauline Marzin1, Sophie Rondeau1, Kimberly A Aldinger2, Jean-Luc Alessandri3, Bertrand Isidor4, Delphine Heron5, Boris Keren5, William B Dobyns2,6, Valérie Cormier-Daire1.   

Abstract

The common genes responsible for overgrowth syndromes play key roles in regulating transcription through histone modification and chromatin modeling. The SETD2 gene encoding a H3K36 trimethyltransferase is implicated in Sotos-like syndrome. This syndrome is characterized by postnatal overgrowth, macrocephaly, obesity, speech delay, and advanced carpal ossification. We report four new patients with constitutional SETD2 mutations and review nine earlier reported patients. Almost all patients presented with macrocephaly associated with advanced stature and obesity in half of the cases. In addition to these principal manifestations, neurodevelopmental disorders are common such as intellectual disability (83%), autism spectrum disorders (89%), and behavioral difficulties (100%) with aggressive outbursts (83%). A variety of features such as joint hypermobility (29%), hirsutism (33%), and naevi (50%) were also reported. Constitutional SETD2 mutations are intragenic loss-of-function variants with truncating (69%) and missense (31%) mutations. Functional studies are necessary to improve understanding of the pathogenicity of some missense SETD2 mutations.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  SETD2; autism spectrum disorder; histone methyltransferases; overgrowth

Mesh:

Substances:

Year:  2019        PMID: 31643139     DOI: 10.1002/ajmg.c.31746

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  5 in total

1.  Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes.

Authors:  Aldesia Provenzano; Andrea La Barbera; Mirko Scagnet; Angelica Pagliazzi; Giovanna Traficante; Marilena Pantaleo; Lucia Tiberi; Debora Vergani; Nehir Edibe Kurtas; Silvia Guarducci; Sara Bargiacchi; Giulia Forzano; Rosangela Artuso; Viviana Palazzo; Ada Kura; Flavio Giordano; Daniele di Feo; Marzia Mortilla; Claudio De Filippi; Gianluca Mattei; Livia Garavelli; Betti Giusti; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Hum Genet       Date:  2020-12-18       Impact factor: 4.132

2.  Neuronal SETD2 activity links microtubule methylation to an anxiety-like phenotype in mice.

Authors:  Matthias Koenning; Xianlong Wang; Menuka Karki; Rahul Kumar Jangid; Sarah Kearns; Durga Nand Tripathi; Michael Cianfrocco; Kristen J Verhey; Sung Yun Jung; Cristian Coarfa; Christopher Scott Ward; Brian Thomas Kalish; Sandra L Grimm; W Kimryn Rathmell; Ricardo Mostany; Ruhee Dere; Matthew Neil Rasband; Cheryl Lyn Walker; In Young Park
Journal:  Brain       Date:  2021-09-04       Impact factor: 15.255

Review 3.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

4.  First presentation of a frameshift mutation in the SETD2 gene of a juvenile psammomatoid ossifying fibroma (JPOF) associated with an aneurysmal bone cyst.

Authors:  A Toferer; A Truschnegg; K Kashofer; C Beham-Schmid; A Beham
Journal:  Diagn Pathol       Date:  2021-10-17       Impact factor: 2.644

5.  The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase.

Authors:  Riyad N H Seervai; Rahul K Jangid; Menuka Karki; Durga Nand Tripathi; Sung Yun Jung; Sarah E Kearns; Kristen J Verhey; Michael A Cianfrocco; Bryan A Millis; Matthew J Tyska; Frank M Mason; W Kimryn Rathmell; In Young Park; Ruhee Dere; Cheryl Lyn Walker
Journal:  Sci Adv       Date:  2020-10-02       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.